Abiralieva 250 mg Tablet: Global Supply & Clinical Profile
Are you looking for a trusted international partner for advanced oncology medications? Primecare Impex, a premier pharmaceutical exporter from India, specializes in the bulk supply and export of Abiralieva 250 mg Tablet (Abiraterone Acetate). We bridge the gap between high-quality Indian pharmaceutical manufacturing and global healthcare systems, ensuring life-saving treatments reach hospitals and patients in New York (USA), Bristol (UK), Sydney (Australia), and Riyadh (Saudi Arabia).
🏥 Clinical Overview: Understanding Abiralieva 250 mg
Abiralieva 250 mg contains Abiraterone Acetate, a potent androgen biosynthesis inhibitor. It is primarily used to treat:
Metastatic Castration-Resistant Prostate Cancer (mCRPC): For cancer that no longer responds to treatments that lower testosterone.
Metastatic High-Risk Castration-Sensitive Prostate Cancer (mHSPC/mCSPC): For newly diagnosed patients where the cancer has already spread.
⚙️ Mechanism of Action: How It Works
Prostate cancer cells typically rely on androgens (male hormones like testosterone) to grow. Abiralieva works through a targeted strategy:
CYP17 Enzyme Inhibition: It selectively inhibits the CYP17 enzyme, which is essential for androgen production.
Triple Suppression: Unlike other treatments, it blocks testosterone production at three sources: the testes, the adrenal glands, and within the prostate tumor itself.
Slowing Progression: By suppressing testosterone to undetectable levels, it starves cancer cells and slows disease progression.
📋 Product Specifications & Usage
Active Ingredient: Abiraterone Acetate 250 mg.
Form: Oral Tablet.
Administration: Typically taken once daily on an empty stomach (at least one hour before or two hours after food).
Combination Therapy: Usually prescribed in combination with low-dose prednisone or prednisolone to manage side effects.
Storage: Store at room temperature (20°C to 25°C) in a dry place, away from direct moisture and sunlight.
Active Ingredient: Abiraterone Acetate 250 mg.
Form: Oral Tablet.
Administration: Typically taken once daily on an empty stomach (at least one hour before or two hours after food).
Combination Therapy: Usually prescribed in combination with low-dose prednisone or prednisolone to manage side effects.
Storage: Store at room temperature (20°C to 25°C) in a dry place, away from direct moisture and sunlight.
⚠️ Safety Information & Side Effects
Patients should be monitored for common side effects, which may include:
Fatigue or feeling weak.
Joint swelling or pain.
Hypertension (high blood pressure).
Hypokalemia (low potassium levels).
Fluid retention.
📄 Documentation & Export Excellence
Primecare Impex manages the entire lifecycle of pharmaceutical export to ensure compliance and safety:
Regulatory Documentation: We provide necessary documentation, including Certificates of Analysis (CoA) and technical dossiers, to facilitate smooth international trade.
Customs Clearance: Expert handling of customs in the USA, UK, Australia, and Saudi Arabia.
Supply Chain Integrity: Robust logistics and temperature-controlled shipping to maintain product efficacy.
PRESCRIPTION MEDICINE: YES
Disclaimer: Abiralieva 250 mg should only be taken under the supervision of a qualified oncologist. This post is for informational purposes and does not constitute medical advice.
📞 Contact PRIMECARE IMPEX — Pharmaceutical Exporter from India
(GROUP OF PRIMECARE IMPEX.PVT.LTD)
🌐 Website:
📦 Business Type: Exporter | Bulk Supplier | Distributor
📲 WhatsApp: +91 9673008130
🔗 Chat Now:
